Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1984 Feb;43(2):593–599. doi: 10.1128/iai.43.2.593-599.1984

Generation of chemotactic activity in serum by Haemophilus influenzae type b.

M F Tosi, S L Kaplan, E O Mason, G J Buffone, D C Anderson
PMCID: PMC264340  PMID: 6607218

Abstract

Studies were performed to characterize chemotactic activity generated by Haemophilus influenzae type b (HiTb) in serum or elaborated independent of serum. Neutrophil aggregometry, Sephadex G-75 gel chromatography, and anti-C5 neutralization studies were used to demonstrate that the complement fragment C5a represented the major chemotactic moiety derived from HiTb-serum interactions. HiTb elaborated minimal chemotactic activity independently. Maximal C5a generation by HiTb as measured by neutrophil response in chemotaxis, shape change, and aggregation assays required specific antibody to the capsular polysaccharide, polyribosyl ribitol phosphate (PRP). Significantly more C5a was generated in pooled normal human serum containing high titers of anti-PRP (determined by an enzyme-linked immunosorbent assay) than in hypogammaglobulinemic serum. Furthermore, C5a generated in hypogammaglobulinemic serum reconstituted with purified high-titer immunoglobulin G, hyperimmune rabbit serum or heat-inactivated normal human serum was comparable to that generated in normal human serum. Absorption of antibody with PRP versus whole HiTb showed a contribution by non-PRP-directed antibody. As shown with the use of C4-deficient guinea pig serum, C5a generation occurred via the alternative complement pathway in nonimmune serum, and activation of the alternative complement pathway was facilitated by specific anti-PRP. C5a generation in test sera was proportional to its opsonic activity for HiTb as assessed by a luminol-chemiluminescence assay. Overall low levels of C5a activity were observed in 13 pediatric patient serum samples obtained during the acute phase of HiTb meningitis, and no pulmonary symptoms or radiographic abnormalities consistent with a leukocyte aggregation syndrome were observed in these patients.

Full text

PDF
593

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson D. C., Edwards M. S., Baker C. J. Luminol-enhanced chemiluminescence for evaluation of type III group B streptococcal opsonins in human sera. J Infect Dis. 1980 Mar;141(3):370–381. doi: 10.1093/infdis/141.3.370. [DOI] [PubMed] [Google Scholar]
  2. Anderson P., Johnston R. B., Jr, Smith D. H. Human serum activities against Hemophilus influenzae, type b. J Clin Invest. 1972 Jan;51(1):31–38. doi: 10.1172/JCI106793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Becker E. L., Showell H. J., Henson P. M., Hsu L. S. The ability of chemotactic factors to induce lysosomal enzyme release. I. The characteristics of the release, the importance of surfaces and the relation of enzyme release to chemotactic responsiveness. J Immunol. 1974 Jun;112(6):2047–2054. [PubMed] [Google Scholar]
  4. Craddock P. R., Hammerschmidt D. E., Moldow C. F., Yamada O., Jacob H. S. Granulocyte aggregation as a manifestation of membrane interactions with complement: possible role in leukocyte margination, microvascular occlusion, and endothelial damage. Semin Hematol. 1979 Apr;16(2):140–147. [PubMed] [Google Scholar]
  5. Craddock P. R., Hammerschmidt D., White J. G., Dalmosso A. P., Jacob H. S. Complement (C5-a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia. J Clin Invest. 1977 Jul;60(1):260–264. doi: 10.1172/JCI108763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Crosson F. J., Jr, Winkelstein J. A., Moxon E. R. Participation of complement in the nonimmune host defense against experimental Haemophilus influenzae type b septicemia and meningitis. Infect Immun. 1976 Oct;14(4):882–887. doi: 10.1128/iai.14.4.882-887.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Densen P., MacKeen L. A., Clark R. A. Dissemination of gonococcal infection is associated with delayed stimulation of complement-dependent neutrophil chemotaxis in vitro. Infect Immun. 1982 Nov;38(2):563–572. doi: 10.1128/iai.38.2.563-572.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hammerschmidt D. E., Weaver L. J., Hudson L. D., Craddock P. R., Jacob H. S. Association of complement activation and elevated plasma-C5a with adult respiratory distress syndrome. Pathophysiological relevance and possible prognostic value. Lancet. 1980 May 3;1(8175):947–949. doi: 10.1016/s0140-6736(80)91403-8. [DOI] [PubMed] [Google Scholar]
  9. Hansen E. J., Robertson S. M., Gulig P. A., Frisch C. F., Haanes E. J. Immunoprotection of rats against Haemophilus influenzae type B disease mediated by monoclonal antibody against a haemophilus outer-membrane protein. Lancet. 1982 Feb 13;1(8268):366–368. doi: 10.1016/s0140-6736(82)91394-0. [DOI] [PubMed] [Google Scholar]
  10. Kaplan S. L., Mason E. O., Jr, Johnson G., Broughton R. A., Hurley D., Parke J. C., Jr Enzyme-linked immunosorbent assay for detection of capsular antibodies against Haemophilus influenzae type b: comparison with radioimmunoassay. J Clin Microbiol. 1983 Nov;18(5):1201–1204. doi: 10.1128/jcm.18.5.1201-1204.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kaplan S. L., Umstead C. L., Mason E. O., Anderson D. C., Parke J. C., Jr, Feigin R. D. Assessment of Haemophilus influenzae type b opsonins by neutrophil chemiluminescence. J Clin Microbiol. 1981 Mar;13(3):532–539. doi: 10.1128/jcm.13.3.532-539.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Keller H. U., Hess M. W., Cottier H. The in vitro assessment of leucocyte chemotaxis. Antibiot Chemother (1971) 1974;19:112–125. doi: 10.1159/000395427. [DOI] [PubMed] [Google Scholar]
  13. Laxalt K. A., Kozel T. R. Chemotaxigenesis and activation of the alternative complement pathway by encapsulated and non-encapsulated Cryptococcus neoformans. Infect Immun. 1979 Nov;26(2):435–440. doi: 10.1128/iai.26.2.435-440.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Myerowitz R. L., Norden C. W., Demchak T. A. Significance of noncapsular antigens in protection against experimental Haemophilus influenzae type b disease: cross-reactivity. Infect Immun. 1978 Aug;21(2):619–626. doi: 10.1128/iai.21.2.619-626.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Newman S. L., Waldo B., Johnston R. B., Jr Separation of serum bactericidal and opsonizing activities for Haemophilus influenzae type b. Infect Immun. 1973 Sep;8(3):488–490. doi: 10.1128/iai.8.3.488-490.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. POLSON A., POTGIETER G. M., LARGIER J. F., MEARS G. E., JOUBERT F. J. THE FRACTIONATION OF PROTEIN MIXTURES BY LINEAR POLYMERS OF HIGH MOLECULAR WEIGHT. Biochim Biophys Acta. 1964 Mar 16;82:463–475. doi: 10.1016/0304-4165(64)90438-6. [DOI] [PubMed] [Google Scholar]
  17. Santosham M., Moxon E. R. Detection and quantitation of bacteremia in childhood. J Pediatr. 1977 Nov;91(5):719–721. doi: 10.1016/s0022-3476(77)81022-6. [DOI] [PubMed] [Google Scholar]
  18. Scheifele D. W., Daum R. S., Syriopoulou V. P., Averill D. R., Smith A. L. Haemophilus influenzae bacteremia and meningitis in infant primates. J Lab Clin Med. 1980 Mar;95(3):450–462. [PubMed] [Google Scholar]
  19. Schmeling D. J., Peterson P. K., Hammerschmidt D. E., Kim Y., Verhoef J., Wilkinson B. J., Quie P. G. Chemotaxigenesis by cell surface components of Staphylococcus aureus. Infect Immun. 1979 Oct;26(1):57–63. doi: 10.1128/iai.26.1.57-63.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Smith C. W., Hollers J. C., Patrick R. A., Hassett C. Motility and adhesiveness in human neutrophils. Effects of chemotactic factors. J Clin Invest. 1979 Feb;63(2):221–229. doi: 10.1172/JCI109293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Snyderman R., Gewurz H., Mergenhagen S. E. Interactions of the complement system with endotoxic lipopolysaccharide. Generation of a factor chemotactic for polymorphonuclear leukocytes. J Exp Med. 1968 Aug 1;128(2):259–275. doi: 10.1084/jem.128.2.259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Steinbuch M., Audran R. The isolation of IgG from mammalian sera with the aid of caprylic acid. Arch Biochem Biophys. 1969 Nov;134(2):279–284. doi: 10.1016/0003-9861(69)90285-9. [DOI] [PubMed] [Google Scholar]
  23. Sutton A., Schneerson R., Kendall-Morris S., Robbins J. B. Differential complement resistance mediates virulence of Haemophilus influenzae type b. Infect Immun. 1982 Jan;35(1):95–104. doi: 10.1128/iai.35.1.95-104.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Tarr P. I., Hosea S. W., Brown E. J., Schneerson R., Sutton A., Frank M. M. The requirement of specific anticapsular IgG for killing of Haemophilus influenzae by the alternative pathway of complement activation. J Immunol. 1982 Apr;128(4):1772–1775. [PubMed] [Google Scholar]
  25. Van Epps D. E., Garcia M. L. Enhancement of neutrophils function as a result of prior exposure to chemotactic factor. J Clin Invest. 1980 Aug;66(2):167–175. doi: 10.1172/JCI109841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Webster R. O., Larsen G. L., Henson P. M. In vivo clearance and tissue distribution of C5a and C5a des arginine complement fragments in rabbits. J Clin Invest. 1982 Dec;70(6):1177–1183. doi: 10.1172/JCI110716. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Weisdorf D. J., Hammerschmidt D. E., Jacob H. S., Craddock P. R. Rapid in vivo clearance of C5ades arg: a possible protective mechanism against complement-mediated tissue injury. J Lab Clin Med. 1981 Dec;98(6):823–830. [PubMed] [Google Scholar]
  28. Weller P. F., Smith A. L., Smith D. H., Anderson P. Role of immunity in the clearance of bacteremia due to Haemophilus influenzae. J Infect Dis. 1978 Oct;138(4):427–436. doi: 10.1093/infdis/138.4.427. [DOI] [PubMed] [Google Scholar]
  29. Wilkinson P. C. Leukocyte locomotion and chemotaxis: effects of bacteria and viruses. Rev Infect Dis. 1980 Mar-Apr;2(2):293–318. doi: 10.1093/clinids/2.2.293. [DOI] [PubMed] [Google Scholar]
  30. Zigmond S. H., Hirsch J. G. Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor. J Exp Med. 1973 Feb 1;137(2):387–410. doi: 10.1084/jem.137.2.387. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES